title: [Evaluation of anthrax vaccination in Denmark].
abstract: The aim of this short review is to present the Danish experience with the U.K. anthrax vaccine as compared with international reviews regarding the immunological response, efficiency, safety and adverse reactions of the U.K. and U.S. anthrax vaccines.
authors.affiliation: Statens Serum Institut, Center for Biologisk Beredskab og Autoimmunafdelingen, København S. khb@ssi.dk
authors.forename: Kristian Hveysel
authors.initials: KH
authors.lastname: Bork
authors.forename: Erik Deichmann
authors.initials: ED
authors.lastname: Heegaard
authors.forename: Jesper
authors.initials: J
authors.lastname: Nielsen
authors.forename: Ewa
authors.initials: E
authors.lastname: Kogutowska
authors.forename: Nils Henrik Helweg
authors.initials: NH
authors.lastname: Heegaard
mesh_terms: D000881:Anthrax / Q000517:prevention & control*; D022122:Anthrax Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000592:standards*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D023482:Bioterrorism / Q000517:prevention & control*; D002939:Ciprofloxacin / Q000008:administration & dosage; D003718:Denmark; D006801:Humans; D012449:Safety
chemical_list: D022122:Anthrax Vaccines; D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin